Minnie Kuo

CIK: 0002101360

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (12.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (37.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PLRX

PLIANT THERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
55.2K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
150K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
150K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
40K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
40K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
55.2K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Jan 22, 2026
Award(A)
Stock Option (Right to Buy)
Direct
300K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Jan 20, 2026
Sale(S)
Direct
6.9K shares at avg. $1.28$9K

		Type	Shares	Price		Ownership
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	55,200	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	150,000	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	150,000	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	40,000	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	40,000	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	55,200	-	-	Direct
Jan 22, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	300,000	-	-	Direct
Jan 20, 2026	PLRX PLIANT THERAPEUTICS, INC.	Sale(S)	6,917	$1.28	$8,854	Direct

1-8 of 8 transactions

About Kuo Minnie

Kuo Minnie (SEC CIK 0002101360) files insider reports with the SEC as Chief Operating Officer of PLIANT THERAPEUTICS, INC. (PLRX).

Signal8 holds 4 ownership filings by Kuo Minnie (1 Form 3, 3 Form 4), filed between Dec 22, 2025 and Apr 17, 2026. Those filings report 8 transactions, from Jan 20, 2026 to Apr 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kuo Minnie's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Kuo Minnie

Apr 17, 2026: Grant or award of PLRX derivative securities (Form 4, code A).
Apr 17, 2026: Disposition to issuer transaction of PLRX derivative securities (Form 4, code D).
Apr 17, 2026: Grant or award of PLRX derivative securities (Form 4, code A).
Apr 17, 2026: Disposition to issuer transaction of PLRX derivative securities (Form 4, code D).
Apr 17, 2026: Grant or award of PLRX derivative securities (Form 4, code A).

Other insiders filing for PLIANT THERAPEUTICS, INC. (PLRX)

Raben David, Chief Medical Officer
Iannone Robert, Director
Borellini Flavia, Director
CROWELL GAYLE A, Director
MCCOURT Thomas A, Director
Krognes Steve E., Director

How to read Form 4 transaction codes